Fundraising FoxHanne Capital
Venture capitalShanghai · Seed–Growth · 2 people tracked
Find your way into Hanne Capital
Sign up to see every warm intro you have to Hanne Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hanne Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Founded in early 2017, Hanne Capital specializes in early- and growth-stage investing within the Greater China healthcare sector, spanning biopharmaceuticals, medical devices, and healthcare services. Its founding partners previously held senior roles at leading private equity funds and major multinational pharmaceutical and device companies. The firm seeks high-potential companies led by trustworthy management teams with strong execution ability, and works closely with portfolio companies as a trusted advisor on strategy, business development, cross-border IP transactions, and operational improvement. The partner team has historically invested in dozens of Chinese healthcare companies with cumulative investment exceeding $500 million, many of which have gone public.
Source: firm website, verified Oct 2, 2026.
Team · 2 people
from public directories
What they invest in
from 2 of 11 portfolio companiesHealthtech ×2Biotech ×1Medical Devices ×1
HQs:China×2
Investments · 11 tracked
founders shown can be your intro pathGuangdong HEC Pharmaceutical, founded in 2003, is a comprehensive pharmaceutical company engaged in the R&D, manufacturing, and commercialization of drugs, with a focus on innovative drugs as well as improved new drugs, generics, and biosimilars.
BiotechHealthtech
Endovastec (心脉医疗) develops and manufactures aortic and peripheral vascular interventional medical devices, including aortic stent systems used in clinical treatment.
HealthtechMedical DevicesShanghai, CN
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Vessix Vascular万春药业再鼎医药启明医疗-B奥精医药安必平归创通桥欧博方医药赛诺医疗
Frequently asked questions
- How many investments has Hanne Capital made?
- Hanne Capital has 11 tracked investments.
- What stage does Hanne Capital invest at?
- Hanne Capital invests at the Seed, Series A, Series B, Growth stages.
- What sectors does Hanne Capital focus on?
- Hanne Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Hanne Capital located?
- Hanne Capital is headquartered in Shanghai, CN.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.